Abstract: A retractable cable combined with a smartphone/tablet holder contains: a roller and a removable support connected with the roller, and the roller includes a casing, a rotatable disc, a spiral torsion spring, and a data transfer cable. The casing includes a first cover and a second cover which are connected together to define an accommodation space so as to house the rotatable disc in which the spiral torsion spring is fixed, and the data transfer cable inserts through and rolls on the rotatable disc. A USB plug of the data transfer cable is accommodated beside a connecting piece of the first cover, and a terminal portion of the data transfer cable is housed on a second joining sheet of the second cover. Preferably, the terminal portion of the data transfer cable matches with a USB slot of a smartphone or a tablet.

Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic ovarian cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovarian, identifying ovarian tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovarian tissue for treatment and research.

Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic ovarian cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovarian, identifying ovarian tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovarian tissue for treatment and research.

Abstract: A chair capable of being adjusted as a chaise comprises a cushion assembly including a first cushion, a second cushion and a third cushion; a first rotary shaft being used to pivotally connect the first cushion and the second cushion; a second rotary shaft being used to pivotally connect the second cushion and the third cushion; an adjusting unit installed below the first cushion; a chair support structure being installed between the first cushion, a second cushion and a third cushion; the chair support structure including an assisting support frame and a support frame; the assisting support frame installed between the first cushion and the third cushion; and the support frame being installed below the third cushion.

Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic ovarian cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating ovarian cancer and non-cancerous disease states in ovarian, identifying ovarian tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered ovarian tissue for treatment and research.

Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast, intestine and colon, lung, ovarian or prostate cancer and non-cancerous disease states in breast, intestine and colon, lung, ovarian or prostate, identifying breast, intestine and colon, lung, ovarian or prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention.

Abstract: The present invention relates to newly identified nucleic acid molecules and polypeptides present in normal and neoplastic cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions containing the nucleic acid molecules, polypeptides, antibodies, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating breast, intestine and colon, lung, ovarian or prostate cancer and non-cancerous disease states in breast, intestine and colon, lung, ovarian or prostate, identifying breast, intestine and colon, lung, ovarian or prostate tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention.

Abstract: A human AZU-1 gene, mutants, variants and fragments thereof. Protein products encoded by the AZU-1 gene and homologs encoded by the variants of AZU-1 gene acting as tumor suppressors or markers of malignancy progression and tumorigenicity reversion. Identification, isolation and characterization of AZU-1 and AZU-2 genes localized to a tumor suppressive locus at chromosome 10q26, highly expressed in nonmalignant and premalignant cells derived from a human breast tumor progression model. A recombinant full length protein sequences encoded by the AZU-1 gene and nucleotide sequences of AZU-1 and AZU-2 genes and variant and fragments thereof. Monoclonal or polyclonal antibodies specific to AZU-1, AZU-2 encoded protein and to AZU-1, or AZU-2 encoded protein homologs.

Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.

Abstract: The invention provides a cDNA which encodes a MRTM. It also provides for the use of the cDNA, fragments, variants, and complements thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly breast cancer. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.

Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in senescent cells and tissues and which may be used in their entirety or in part as to diagnose, to stage, to treat, or to monitor the treatment of a subject with cancer or a proliferative disease.

Abstract: The invention provides a cDNA which encodes a STEAP-related protein. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of prostate cell proliferative disorders, particularly prostate hyperplasia and prostate cancer. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.

Abstract: The present invention relates to a combination comprising a plurality of cDNAs which are differentially expressed in breast cancer and which may be used in their entirety or in part as to diagnose, to stage, to treat, or to monitor the treatment of a subject with a breast cancer.

Abstract: A handy toy for throwing and catching, which includes a substantially spherical body comprised of a core holder and a big amount of unitary filaments which have each an elastic, circular rod-like structure and which uniformly radiate from the core holder; and a rust-proof steel ball inserted inside the core holder. The filaments and the core holder are unitarily made of elastic plastic material through injection molding process to form a soft and elastic spherical body for amusement.

Abstract: A novel process for the more efficient extraction with an edible oil of the red carotenoid pigment astaxanthin, from the chitinous shells and proteinaceous tissues of shellfish to provide an astaxanthin enriched dietary food ingredient, and other food products. A crustacean waste, e.g. a crawfish waste, is ground in an attrition mill to separate the soft proteinaceous tissue from the chitinous shell, the chitinous shell is removed, and the separated proteinaceous tissue is acidified to pH ranging from about 4 to 5.5 sufficient to suppress microbial degradation and improve overall pigment recovery. The acidified proteinaceous tissue is cooked, as a puree, in a kettle and extracted with certain edible oils at critical concentrations, at specified critical temperature-time relationships.